Xspray Pharma’s Nomination Committee for the Annual General Meeting 2021
Press release 2020-10-21
Xspray Pharma AB (Nasdaq Stockholm: XSPRAY) publishes the Nomination Committee’s composition for the Annual General Meeting in 2021.
The Nomination Committee, which has been appointed in accordance with the principles adopted by the Annual General Meeting on 14 May 2020, consists of:
- Gillis Cullin, appointed by Östersjöstiftelsen
- Johan Gyllenswärd, appointed by Ribbskottet AB
- Caroline Sjösten, appointed by Swedbank Robur Fonder
- Michael Wolff Jensen, Chairman of the Board of Directors
The Nomination Committee shall, before the Annual General Meeting 2021, prepare proposals for the election of Chairman and other members of the Board of Directors, the election of Chairman of the Annual Meeting, election of auditors, the determination of fees and matters pertaining thereto.
Shareholders who wish to submit proposals to the Nomination Committee prior to the Annual General Meeting on May 20, 2021 can do so via e-mail to firstname.lastname@example.org before April 1, 2021.
For further information about the nomination committee, please contact:
Michael Wolff Jensen, Chairman of the board of directors, Xspray Pharma AB